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	 Abstract
Objectives: The aim of our study was to evaluate whether mild to moderate infant respiratory distress syndrome 
(RDS) treated with nasal continuous positive airway pressure (NCPAP) might affect the pulmonary function in 
school-aged children. 
Material and methods: 50 children, aged 10.2±2.8 years, with a history of RDS and 90 controls without a 
neonatal history of lung diseases, matched for age and gestational age at birth, were studied. Pulmonary function 
was assessed by spirometry and oxygen saturation measured by pulse oximeter. 
Results: The incidence of respiratory tract infections within the first 6 years after discharge from the intensive care 
neonatal unit was higher in the RDS group than in controls (P<0.05). Spirometric parameters of the pulmonary 
function were comparable in both groups. Oxygen saturation was significantly lower in the RDS group (96.2±7 vs. 
97.3±7%; P<0.05). A significant negative correlation between spirometric parameters and the duration of NCPAP 
application and the duration of oxygen supplementation has been found. 
Conclusions: Pulmonary function assessed by spirometry was normal in school-aged children with infant RDS. 
However, spirometric parameters were negatively correlated with the duration of NCPAP and the duration of oxygen 
supplementation. In comparison with the controls, children with infant RDS had a higher incidence of respiratory 
tract infections (laryngitis, acute bronchitis and pneumonia) within the first 6 years of life, as well as lower oxygen 
saturation.  
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Introduction
Prematurity	is	frequently	complicated	by	respiratory	distress	
syndrome	(RDS)	and	additional	defects	in	other	organ	functions	
[1].	Despite	 huge	 advances	 in	 neonatal	 care,	RDS	 remains	 the	
most	common	single	cause	of	death	in	the	first	month	of	neonatal	
life.	RDS	is	frequently	associated	with	some	metabolic	disorders,	
such	 as	 acidosis,	 low	 blood	 pressure,	 patent	 ductus	 arteriosus,	
retinopathy	 of	 prematurity,	 intracranial	 hemorrhages	 and	 lung	
diseases	 (pneumothorax,	 pneumomediastinum,	 pneumonia,	
bronchopulmonary	dysplasia,	bleeding	into	the	lung).	
Nasal	continuous	positive	airway	pressure	(NCPAP)	delivered	
by	nasal	prongs	has	been	widely	applied	in	neonatal	intensive	care	
units	for	treatment	of	infant	RDS.	Early treatment	with	NCPAP	
can	prevent or	temporarily	compensate	for	the	increased	alveolar-
retraction forces	 that	are	a	consequence	of	high	surface	 tension	
caused by	a	deficiency	of	surfactant.	It	has	been	shown	that		the	
application	of	NCPAP	and	treatment	with	surfactant	are	effective	
in	 reducing	 the	 mortality	 and	 morbidity	 rates	 associated	 with	
RDS	 [2-7].	Moreover,	 early	 treatment	 of	 very	 preterm	 infants	
with	RDS	using	NCPAP	is	effective	in	decreasing	the	need	for	
mechanical	ventilation,	with	 its	related	adverse	effects,	such	as	
upper	airway	damage,	sepsis	and	bronchopulmonary	dysplasia	[8-
12].	Although	the	majority	of	studies	have	suggested	that	NCPAP	
is	a	safe	way	of	providing	respiratory	support	to	neonates	at	risk	
of,	or	actually	experiencing	respiratory	failure	[4-8,	12],	Morley	
et	al.	have	demonstrated	in	a	recent	study	that,	in	infants	born	at	
25	to	28-weeks	gestation,	NCPAP	did	not	significantly	reduce	the	
rate	of	death	or	bronchopulmonary	dysplasia,	as	compared	with	
intubation	[9].	
Much	 less	 is	 known	about	 long-term	pulmonary	 functions	
in	 infants	 with	 RDS	 receiving	 NCPAP	 and	 it	 remains	 unclear	
whether	 the	 well-demonstrated	 short-term	 benefits	 of	 this	
treatment	 translate	 into	 significant	 reductions	 in	 chronic	 lung	
disease	in	childhood	and	adolescence.		
Aim
The	 aim	 of	 our	 study	 was	 to	 evaluate	 whether	 mild	 to	
moderate	 infant	 RDS	 requiring	NCPAP	 application	 during	 the	
neonatal	 period	would	have	 an	 impact	on	pulmonary	 function,	
as	 assessed	 by	 spirometry	 and	 pulse	 oximetry,	 of	 school-aged	
children.
Materials	and	methods
Study Population
The	study	was	performed	on	140	Caucasian	children	aged	
5-15	 years,	 born	 in	 the	 Clinic	 of	 Pathology	 of	 Labour	 and	
Delivery	 in	Szczecin,	Poland.	The	study	group	consisted	of	50	
children	with	mild	 to	moderate	 infant	 RDS,	 requiring	NCPAP	
during	 the	 neonatal	 period	 (Hudson	 type	 of	 nasal	 prongs,	
Kwapisz	 Co.,	 Warsaw,	 Poland).	 The	 RDS	 was	 diagnosed	 by	
widely	 accepted	 criteria	 [4,	 5].	 Infants	 with	 other	 respiratory	
pathologies	requiring	NCPAP	during	the	neonatal	period,	such	as	
wet	lung,	asphyxia,	or	pneumonia,	as	well	as	infants	with	RDS	
requiring	mechanical	ventilation	were	not	included	into	the	study.	
The	control	group	consisted	of	90	healthy,	age-matched	children.	
From	our	medical	records	we	randomly	selected		children	with	a	
similar	range	of	gestational	age	at	birth	as	in	the	RDS	group,	born	
by	uncomplicated	delivery	and	without	pulmonary	complications	
during	the	neonatal	period.	In	all	cases,	parental	written	informed	
consent	was	obtained	for	the	participation	in	the	study.	
By	 reviewing	 medical	 records	 from	 the	 neonatal	 period,	
the	 following	 data	were	 collected:	 complications	 of	 pregnancy	
(preeclampsia,	 pregravid	 or	 gestational	 diabetes	 mellitus,	 oral	
and	 intravenous	 tocolysis,	 infection	 and	 premature	 rupture	 of	
membranes),	 mode	 of	 delivery,	 gestational	 age	 at	 birth,	 birth	
weight	 and	 body	 length,	 Apgar	 score	 at	 5	 minutes,	 as	 well	
as	 respiratory	 complications	 (air	 leak	 syndrome,	 pulmonary	
hemorrhage	and	nasal	mucosal	damage)	and	infections	during	the	
neonatal	period	(pneumonia,	meningitis	or	sepsis).	
	 Streszczenie	
Cel pracy: Celem pracy była ocena funkcji płuc u dzieci szkolnych leczonych w okresie noworodkowym metodą 
NCPAP z powodu łagodnych lub średnio nasilonych zaburzeń oddychania. 
Materiał i metody: Badaniami objęto 50 dzieci w wieku 10,2±2,8 lat z przebytą w okresie noworodkowym niewy-
dolnością oddechową  i  90 dzieci w podobnym wieku kalendarzowym i urodzonych w podobnym wieku ciążowym, 
ale bez objawów niewydolności oddechowej w okresie noworodkowym. Funkcje płuc oceniono poprzez zastoso-
wanie badania spirometrycznego i oceny przezskórnego wysycenia tlenem hemoglobiny.
Wyniki: W ciągu pierwszych 6 lat życia dzieci wymagające wsparcia oddechowego metodą NCPAP chorowały 
istotnie częściej na infekcje układu oddechowego (p <0,05) niż dzieci nie wymagające takiego leczenia. Oceniane 
parametry spirometryczne były podobne w obu grupach. Przezskórna saturacja była istotnie niższa w grupie dzieci 
leczonych NCPAP niż w grupie kontrolnej. Stwierdzone występowanie ujemnej korelacji między parametrami spiro-
metrycznymi a czasem trwania leczenia metoda NCAP i liczba dni tlenoterapii.
Wnioski: Dzieci szkolne z przebytą łagodną lub umiarkowaną niewydolnością oddechową w okresie noworodko-
wym nie wykazują różnic w funkcji płuc ocenianych badaniem spirometrycznym. Parametry spirometryczne korelują 
negatywnie z okresem czasu stosowania NCPAP i suplementacji tlenem. Dzieci z niewydolnością oddechową 
w wywiadzie częściej chorują na zapalenie krtani, zapalenie oskrzeli i zapalenie płuc w okresie przedszkolnym i mają 
niższą saturację w wieku szkolnym.
 Key words: płuca / okres noworodkowy / zaburzenia oddychania / 
        / niewydolność oddechowa / układ oddechowy / 
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Additionally,	other	complications	in	the	neonatal	period,	such	
as	retinopathy	of	prematurity,	intraventricular	hemorrhage,	patent	
ductus	arteriosus,	anemia	and	hyperbilirubinemia,	were	recorded.	
Using	other	available	medical	records,	we	also	collected	data	on	
respiratory	 tract	 infections	 (acute	 laryngitis,	 acute	bronchiolitis	
and	pneumonia)	after	discharge	from	the	neonatal	intensive	care	
unit	until	the	day	of	the	spirometric	assessment.
Anthropometric Measurements and Assessment of Oxygen 
Saturation 
Weight	 was	 measured	 on	 a	 standard	 medical	 balance	 for	
children	and	height	was	measured	by	a	fixed	stadiometer.	Before	
spirometry,	 after	 a	 10-minute	 rest,	 heart	 rate	 and	 oxygenation	
were	 measured	 by	 a	 pulse	 oximeter	 (Dräger	 Pulse	 Oximeter;	
Medical	System	IT	GmbH,	Freiburg,	Germany).
Pulmonary Function Studies (Spirometry)
The	pulmonary	function	was	assessed	by	spirometry	(Lungtest	
500;	MES,	Cracow,	Poland).	The	spirometry	was	performed	in	
children	without	 cough	 or	wheezing	 for	more	 than	 two	weeks	
within	 a	 year	 before	 the	 spirometric	 evaluation,	 and	 known	
chronic	 pulmonary	 disease.	All	measurements	were	 performed	
at	the	same	time	each	day,	between	4	and	6	pm.	The	spirometer	
was	calibrated	before	each	test,	and	current	values	of	atmospheric	
pressure,	 temperature	 and	 relative	 humidity	 were	 included	 for	
correction	of	the	pulmonary	function	parameters.	The	results	of	
the	measurements	were	also	corrected	for	body	temperature	and	
saturation.	Spirometry	was	performed	in	a	seated	position	with	the	
head	tilted	back.	The	pulmonary	function	testing	and	its	duration	
were	performed	according	to	the	standards	recommended	by	the	
American	 Thoracic	 Society	 [13].	 The	 results	 were	 calculated	
from	three	comparable	values	of	parameters,	which	did	not	differ	
by	more	than	5%	(or	0.1	liter)	and	were	determined	from	the	best	
forced	vital	capacity	(FVC)	result	[14].	
The	 following	 pulmonary	 function	 parameters	 were	
measured:	 1-second	 forced	 expiratory	 volume	 (FEV1),	 forced	
expiratory	 vital	 capacity	 (FVC
EX
),	 forced	 inspiratory	 vital	
capacity	 (FVC
IN
),	 peak	 inspiratory	 flow	 (PIF),	 vital	 capacity	
(VC),	 inspiratory	capacity	 (IC),	 total	 lung	capacity	 (TLC),	and	
peak	expiratory	flow	(PEF).	
The	 protocol	 and	 parental	 informed	 consent	 form	 were	
approved	by	the	institutional	review	board.			
Statistical Analysis
The	 distribution	 of	 continuous	 variables	 was	 tested	 for	
normality	 by	 the	 Shapiro-Wilk	 test.	 The	 differences	 between	
children	with	a	history	of	RDS	and	healthy	controls	were	tested	
by	the	Wilcoxon	test	or	Mann-Whitney	nonparametric	U	test	as	
appropriate.	Linear	correlation	and	regression	or	non-parametric	
regression	 analyses	were	 used	 to	 test	 for	 associations	 between	
spirometric	 parameters,	 duration	 of	 NCPAP	 and	 duration	 of	
oxygen	therapy	after	weaning	from	NCPAP.		
Results
Baseline	characteristics	of	the	studied	population	at	birth	are	
provided	 in	Table	 I.	 In	 comparison	with	 the	 controls,	 children	
receiving	 NCPAP	 during	 the	 neonatal	 period	 had	 significantly	
lower	birth	weight	and	height.	In	the	NCPAP	group,	the	gestational	
age	ranged	from	29	to	39	weeks	and	was	<37	weeks	in	62%	of	
newborn	infants.	
In	this	group	7	infants	were	born	at	29-32	weeks	gestation	
(mean	 birth	 weight	 1629.0±170g),	 24	 infants	 at	 33-36	 weeks	
(birth	weight	2455±232g)	and	19	 infants	at	37-39	weeks	(birth	
weight	3235±301g).	In	the	control	group,	12	infants	were	born	
at	28-32	weeks	gestation	(mean	birth	weight	1721±201g),	45	at	
33-36	weeks	(birth	weight	2501	±	280	g)	and	33	at	37-39	weeks	
(birth	weight	3299±312g),	respectively.	All	newborn	infants	from	
the	control	group	had	normal	Apgar	scores	at	birth,	whereas	in	
the	NCPAP	group,	normal	score	were	found	in	only	60%	of	the	
cases.	
Table I. Baseline characteristic at birth of the studied population. 
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As	 summarized	 in	 Table	 II,	 abdominal	 distension,	
intraventricular	 hemorrhage	 and	 hyperbilirubinemia	 were	
frequent	complications	in	the	NCPAP	group	(overall,	in	44	of	50	
infants).	 Similarly,	 the	 incidence	 of	 respiratory	 tract	 infections	
(laryngitis,	 acute	 bronchitis	 and	 pneumonia)	 within	 the	 first	 6	
years	after	discharge	 from	the	 intensive	care	neonatal	unit	was	
higher	in	the	NCPAP	group	than	in	healthy	controls.	(Table	III).	
The	 highest	 incidence	 of	 acute	 bronchitis	 and	 pneumonia	
that	 occurred	 within	 the	 first	 2	 years	 after	 discharge	 was	 in	
NCPAP	 infants	born	at	33-36	weeks	gestation	 (OR=2.85,	95%	
CI:	 1.09-7.5;	 P<0.05	 and	OR=3.29,	 95%CI:	 1.1-9.88;	 P<0.05,	
respectively).	Children	from	the	control	group	were	heavier,	taller	
and	 had	 higher	 oxygen	 saturation	 as	 compared	 to	 the	NCPAP	
group.	 (Table	 IV).	 However,	 after	 adjustment	 for	 weight	 and	
height,	 spirometric	parameters	of	 the	pulmonary	 function	were	
comparable	in	both	groups.	(Table	V).	
In	 the	 NCPAP	 group,	 the	 duration	 of	 respiratory	 support	
ranged	from	23	to	238	hours	(median:	54	hours)	and	the	fraction	
of	 inspired	 oxygen	 was	 0.40-0.89%	 (median:	 0.53%).	 The	
duration	of	oxygen	supplementation	after	weaning	from	NCPAP	
ranged	from	2	to	25	days	(median:	8.3	days),	and	was	the	longest	
in	infants	born	at	28-32	weeks	gestation	(median:	10.4	days),	as	
compared	 with	 those	 born	 at	 33-36	 weeks	 gestation	 (median:	
3.4	days;	P<0.001)	or	37-39	weeks	gestation	(median:	2.6	days;	
P<0.001).	
There	were	weak	but	significant	negative	correlations	found	
between	 the	 duration	 of	 NCPAP	 or	 oxygen	 supplementation	
after	weaning	 from	 respiratory	 support	 and	 all	 the	 spirometric	
parameters	of	the	pulmonary	function.	(Table	VI).	
Discussion
Chronic	 lung	 diseases	 in	 infants	 is	 a	 heterogeneous	 group	
of	 diseases	 that	 usually	 evolves	 from	 an	 acute,	 prematurity-
associated	 newborn	 respiratory	 disorder.	 These	 disorders,	
such	 as	RDS,	 and	 their	 subsequent	 treatments	may	 predispose	
infants	 to	 the	development	of	chronic	 lung	disease.	It	has	been	
suggested	that	in	mid-childhood	(5-12	years	of	age),	prematurity	
is	 associated	 with	 an	 excess	 of	 various	 respiratory	 symptoms,	
such	 as	 chronic	 cough,	wheezing,	 asthma	 or	 upper	 respiratory	
tract	infections	[12,	15-17].	
Table II. Complications during the neonatal period. 
Table III. Incidence of respiratory tract infections after discharge from the neonatal intensive care unit. 
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This	has	been	reported	both	in	low	and	very	low	birth	weight	
babies,	 mainly	 in	 those	 who	 required	 prolonged	 respiratory	
support,	or	developed	bronchopulmonary	dysplasia.	In	the	present	
study,	 we	 found	 a	 history	 of	 higher	 incidences	 of	 laryngitis,	
bronchitis	and	bronchopneumonia	during	 the	first	 two	years	of	
life	in	school-aged	children	who	were	treated	with	NCPAP	due	
to	the	RDS.	However,	in	older	children,	aged	3	to	15	years,	the	
incidence	of	respiratory	tract	infections	was	similar	to	that	of	the	
healthy	 controls.	 62%	of	 our	 patients	 in	 the	 infant	RDS	group	
were	born	<37	weeks	gestation.	
Both	 prematurity	 per	 se	 as	well	 as	 low	 birth	weight	 have	
been	 suggested	 as	 independent	 risk	 factors	 for	 impairment	 of	
pulmonary	functions	in	childhood	[15,	17,	18,	19]	.	
Furthermore,	 we	 found	 that	 school-aged	 children	 (5-15	
years	of	age)	with	infant	RDS	had	normal	pulmonary	function,	
as	assessed	by	spirometric	measurements,	which	may	suggest	an	
improvement	in	pulmonary	function	over	a	longer	period.	Several	
factors	 might	 contribute	 to	 this	 improvement.	 The	 damage	 of	
respiratory	 bronchioles	 in	 survivors	 of	 RDS	 during	 the	 first	
year	of	life	may	be	counteracted	by	later	catch-up	growth	[17].	
Parenchymal	 lung	growth	in	 the	first	years	of	 life	 is	associated	
with	the	addition	of	new	alveoli	and	by	the	formation	of	alveolar	
ducts.	As	 alveolar	 development	 is	 generally	 completed	 before	
8	years	of	age	[20],	pulmonary	abnormalities	documented	after	
this	age	would	suggest	a	long-standing	impairment	of	pulmonary	
function.	
Low	 arterial	 oxygen	 pressure	 and	 decreased	 functional	
residual	capacity	have	been	demonstrated	in	 the	early	recovery	
phase	of	RDS	[19].	Some	studies	 reported	normal	 total	airway	
resistance	at	discharge	from	the	neonatal	unit	in	survivors	of	RDS	
who	were	ventilated	with	the	subsequent	increase	of	the	airway	
resistance	in	a	1-year	follow-up	[21].	In	contrast,	Ben-Abraham	
et	al.	 [22]	observed	normal	 lung	volumes,	flow	rates	and	PaO2 
in	 survivors	 of	RDS	 after	 5	 years.	 In	 our	 study,	 children	with	
infant	RDS	had	lower	pulse	oximeter	oxygen	saturation	than	the	
control	subjects	at	5-15	years	of	age.	However,	average	oxygen	
saturation	was	within	normal	range	 in	both	groups	(96.2%	and	
97.3%,	respectively).	
We	found	weak	but	statistically	significant	negative	correlations	
between	spirometric	parameters	of	pulmonary	function,	duration	
of	NCPAP	and	duration	of	oxygen	supplementation	in	the	neonatal	
period.	 There	 have	 been	 no	 previous	 reports	 testing	 for	 such	
associations	 in	 RDS	 survivors	 treated	 with	 NCPAP.	 However,	
the	negative	correlations	found	in	our	study	probably	reflect	only	
the	severity	of	 the	underlying	disease	and	 the	NCPAP	duration	
is	probably	only	a	marker	of	this	severity. Similar	impairment	of	
pulmonary	function	has	been	reported	in	very	low	birth	weight	
children	 with	 and	 without	 bronchopulmonary	 dysplasia	 [19].	
In	very	 low	birth	weight	children	 (<1500g),	 the	FEV1	 to	FVC	
ratio	was	<70%	and	was	inversely	associated	with	the	duration	
of	NCPAP	>28	days,	prolonged	use	of	oxygen	therapy	and	RDS	
[23].	In	contrast,	Kitchen	et	al.	[24]	found	that	FEV1	and	FVC	
were	unrelated	to	bronchopulmonary	dysplasia	or	NCPAP	per	se,	
and	that	abnormalities	of	flow	rates	were	only	seen	in	those	with	
asthma	or	 recurrent	bronchitis	 at	 8	years	of	 age.	Despite	 these	
discrepancies,	 there	 is	 a	 general	 agreement	 that,	 in	 the	 case	of	
very	 low	 birth	 weight	 children,	 a	 significant	 reduction	 in	 the	
incidence	of	chronic	lung	diseases	detected	in	childhood	can	be	
achieved	by	using	a	quality	 improvement	process	 that	 includes	
avoidance	of	 intubation,	adoption	of	new	pulse	oximeter	 limits	
and	early	use	of	NCPAP	[12,	19].	
Our	study	has	several	limitations.	First,	our	study	population	
was	comprised	of	patients	with	mild	 to	moderate	RDS,	 treated	
with	NCPAP	at	a	gestational	age	of	28	to	39	weeks	(average	35.7	
weeks).	
Table IV. Anthropometric measurements and oxygen saturation. 
Table V. Parameters of pulmonary function in children treated with NCPAP 
and healthy controls. 
Table VI. Correlations between parameters of pulmonary function, duration 
of NCPAP and duration of oxygen supplementation.
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Therefore,	our	findings	may	not	apply	to	the	population	of	
very	low	birth	weight	infants	(<32	weeks	of	gestation;	birth	weight	
<1500g)	with	RDS.	Second,	we	did	not	assess	bronchial	airway	
reactivity	and	our	assessment	of	pulmonary	function	was	based	
solely	 on	 the	 spirometric	 results.	 An	 important	 consideration	
is	 whether	 our	 findings	 describing	 apparent	 normalization	 of	
pulmonary	 function	 in	 childhood	 truly	 reflect	 a	 catch-up	 of	
lung	 growth.	 Some	 studies	 reported	 a	 decreased	 sensitivity	 of	
spirometry	 in	 this	age	group	[19].	Further,	spirometry	has	 long	
been	known	 to	be	 insensitive	 to	distal	 airway	obstruction	until	
the	 very	 late	 phases	 [19].	 Thus,	 the	 use	 of	 other	 methods	 of	
evaluating	lung	ventilation	and	lung	growth	might	provide	more	
accurate	 information.	These	methods	 include	measurements	 of	
indices	 of	 overall	 ventilation	 inhomogeneity,	 such	 as	 the	 lung	
clearance	index,	the	noninvasive	assessment	of	lung	growth	with	
the	 use	 of	 labeled	 carbon	monoxide,	 and	 hyperpolarized	gases	
in	magnetic	 resonance	or	pulmonary	high-resolution	 computed	
tomography	[19,	25].	
In	 conclusion,	 pulmonary	 function	 assessed	 by	 spirometry	
was	normal	in	school-aged	children	with	mild	to	moderate	RDS	
treated	with	NCPAP	in	the	neonatal	period.	However,	spirometric	
parameters	 were	 negatively	 correlated	 with	 the	 duration	 of	
NCPAP	and	the	duration	of	oxygen	supplementation.
The	incidence	of	respiratory	tract	infections	(laryngitis,	acute	
bronchitis	and	pneumonia)	within	the	first	6	years	after	discharge	
from	 the	 intensive	 care	 neonatal	 unit	 was	 higher	 in	 the	 infant	
RDS	group	than	in	controls.	
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